Home » Polymedco Launches Epi proColon
Polymedco Launches Epi proColon
May 17, 2016
Polymedco has launched the Epi proColon, a colorectal cancer blood test for patients not able to complete a stool test or colonoscopy, the company announced Monday.
The test, approved last month, falls under a commercialization agreement between Epigenomics AG and Polymedco.
Epi proColon is the first FDA-approved DNA blood test for colorectal cancer screening, according to Polymedco. — Anisa Jibrell
Upcoming Events
-
21Oct